{"id":229229,"date":"2026-01-17T08:25:59","date_gmt":"2026-01-17T14:25:59","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/01\/what-immune-differences-distinguish-latent-autoimmune-diabetes-in-adults-from-type-1-diabetes"},"modified":"2026-01-17T08:25:59","modified_gmt":"2026-01-17T14:25:59","slug":"what-immune-differences-distinguish-latent-autoimmune-diabetes-in-adults-from-type-1-diabetes","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/01\/what-immune-differences-distinguish-latent-autoimmune-diabetes-in-adults-from-type-1-diabetes","title":{"rendered":"What immune differences distinguish latent autoimmune diabetes in adults from type 1 diabetes?"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/what-immune-differences-distinguish-latent-autoimmune-diabetes-in-adults-from-type-1-diabetes2.jpg\"><\/a><\/p>\n<p>Ivan I. Golodnikov &amp; team report a calmer immune response in slower autoimmune diabetes, offering insight into why some patients lose insulin production more gradually:<\/p>\n<p>The figure shows an atlas of PBMC from healthy donors and patients with latent autoimmune diabetes mellitus (LADA) and Type1 <i>Diabetes<\/i> (T1D).<\/p>\n<hr>\n<p>Address correspondence to: Ivan I. Golodnikov, 11 Dm. Ulyanova Street, 117,036 Moscow, Russian. Phone: 7.985.352.05.75; Email: <a href=\"mailto:miloru9@gmail.com\">miloru9@gmail.com<\/a>.<\/p>\n<p>Find articles by Golodnikov, I. in: <a target=\"_blank\" href=\"https:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=search&db=pubmed&term=Golodnikov+I[au>&dispmax=50\"]PubMed<\/a> | <a target=\"_blank\" href=\"https:\/\/scholar.google.com\/scholar?q=%22author%3AI+Golodnikov%22\">Google Scholar<\/a><\/p>\n<p><sup>1<\/sup>Endocrinology Research Centre, Moscow, Russia.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ivan I. Golodnikov &amp; team report a calmer immune response in slower autoimmune diabetes, offering insight into why some patients lose insulin production more gradually: The figure shows an atlas of PBMC from healthy donors and patients with latent autoimmune diabetes mellitus (LADA) and Type1 Diabetes (T1D). Address correspondence to: Ivan I. Golodnikov, 11 Dm. [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,1512],"tags":[],"class_list":["post-229229","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-mobile-phones"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/229229","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=229229"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/229229\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=229229"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=229229"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=229229"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}